Tai Chi for Essential Hypertension

Table 4

Analyses of systolic blood pressure.

Trials		WMD [95% CI]	𝑃 value
Tai Chi versus routine care
24-type Tai Chi versus routine care	1	−10.50 [−10.86,−10.14]	<0.00001
24-type Tai Chi versus routine care	1	−12.36 [−14.76,−9.96]	<0.00001
Tai Chi versus routine care	1	−8.48 [−8.82,−8.14]	<0.00001
24-type Tai Chi versus routine care	1	−24.42 [−26.18,−22.66]	<0.00001
24/48/Yang-type Tai Chi versus routine care	1	−18.30 [−19.37,−17.23]	<0.00001
Yang-type Tai Chi versus routine care	1	−4.34 [−5.20,−3.48]	<0.00001
24-type Tai Chi versus routine care	1	−18.20 [−18.54,−17.86]	<0.00001
12-type Tai Chi versus routine care	1	−15.92 [−18.56,−13.28]	<0.00001
Tai Chi versus routine care	1	−12.97 [−15.10,−10.84]	<0.00001
Tai Chi versus routine care	1	−17.60 [−23.44,−11.76]	<0.00001
Meta-analysis	10	−12.43 [−12.62,−12.24]	<0.00001
Tai Chi versus antihypertensive drugs
Tai Chi versus antihypertensive drugs (reserpine or compound rutin tablets)	1	−14.30 [−14.31,−14.29]	<0.00001
Meta-analysis	1	−14.30 [−14.31,−14.29]	<0.00001
Tai Chi plus antihypertensive drugs versus antihypertensive drugs
Tai Chi plus cilazapril versus cilazapril	1	−7.60 [−9.24,−5.96]	<0.00001
Chen-type Tai Chi plus nifedipine versus nifedipine	1	−24.00 [−28.75,−19.25]	<0.00001
Meta-analysis	2	−9.34 [−10.89,−7.79]	<0.00001